首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1741463

弗雷泽综合征市场（按测试类型、最终用户和地区）

Frasier Syndrome Market, By Test Type (Genetic Testing, Ultrasound Testing, Others), By End User (Hospitals, Diagnostic Centers, Research Institutes, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

出版日期: 2025年03月27日 | 出版商:

Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

简介目录

弗雷泽症候群市场规模预计在 2025 年达到 1.558 亿美元，预计到 2032 年将达到 2.207 亿美元，2025 年至 2032 年的复合年增长率为 5.1%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	1.558亿美元
效能数据	从2020年到2024年	预测期	2025年至2032年
预测期：2025-2032年复合年增长率：	5.10%	2032年价值预测	2.207亿美元

弗雷泽症候群 (FS) 是一种罕见的遗传性疾病，会影响肾臟和性发育。弗雷泽症候群的特征是肾臟疾病，可发展为末期肾功能衰竭，并出现性腺发育不良，导致女性月经停止。

1964年，普拉德博士创造了「弗雷泽症候群」一词。弗雷泽症候群是由位于11号染色体短臂上的WT1基因突变引起的。该基因在胚胎发育过程中对肾臟和性腺的发育起着关键作用。 WT1基因突变会破坏正常的细胞过程，从而导致弗雷泽症候群的特征。

弗雷泽症候群的发生率估计为十万分之一。此病主要影响女性，但也有男性病例报告。弗雷泽症候群的诊断是基于临床特征、基因检测和肾臟组织的组织病理学检查。

市场动态：

弗雷泽综合征市场受多种因素驱动。首先，人们对遗传疾病的认识不断提高，以及先进诊断技术的普及，提高了弗雷泽症候群的诊断率，进而推动了对基因检测和筛检的需求，最终推动了市场的成长。

其次，弗雷泽症候群的盛行率不断上升也促进了市场的成长。对有效的肾臟替代疗法和长期管理策略的需求，催生了对创新治疗方案的需求。

然而，弗雷泽症候群市场也面临一些限制。医护人员和民众对这种罕见疾病的认知度有限，可能导致漏诊和延误治疗。此外，基因检测和专科治疗的高昂费用也为患者及其家属带来了挑战。

儘管面临这些挑战，弗雷泽症候群市场仍存在许多机会。标靶治疗和个人化医疗的发展有望改善弗雷泽症候群患者的预后。此外，研究机构、製药公司和倡导团体之间的合作可以促进对更优诊断工具和治疗方法的研究。

本研究的主要特点

本报告对全球弗雷泽症候群市场进行了详细分析，包括预测期 2025 年至 2032 年的市场规模和复合年增长率（以 2024 年为基准年）。
它揭示了各个领域的潜在商机，并说明了该市场的引人注目的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，介绍了全球弗雷泽症候群市场的主要企业概况。
本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
本研究报告针对该产业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过用于分析全球弗雷泽症候群市场的各种策略矩阵来更轻鬆地做出决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 155.8 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.10%	2032 Value Projection:	USD 220.7 Mn

Dr. Prader in 1964 coined the term Frasier syndrome. It is caused by mutations in the WT1 gene located on the short arm of chromosome 11. This gene plays a crucial role in the development of the kidneys and gonads during embryogenesis. Mutations in the WT1 gene disrupt normal cellular processes, leading to the characteristic features of Frasier syndrome.

The incidence of Frasier syndrome is estimated to be around 1 in 100,000 live births. It predominantly affects females, although rare cases have been reported in males as well. The diagnosis of Frasier syndrome is based on clinical features, genetic testing, and histopathological examination of kidney tissue.

Market Dynamics:

The market for Frasier syndrome is driven by several factors. Firstly, rising awareness about genetic disorders and the availability of advanced diagnostic techniques have led to an increased diagnosis rate of Frasier syndrome. This has resulted in a growing demand for genetic tests and screenings, driving market growth.

Secondly, the increasing prevalence of Frasier syndrome has also contributed to market expansion. The need for effective renal replacement therapies and long-term management strategies has created a demand for innovative treatment options.

However, the market for Frasier syndrome faces certain restraints as well. Limited awareness among healthcare professionals and the general public about this rare disorder can lead to underdiagnosis and delayed treatment. Moreover, the high cost of genetic testing and specialized treatments poses a challenge for patients and their families.

Despite these challenges, the market for Frasier syndrome presents several opportunities. The development of targeted therapies and personalized medicine approaches holds promise for improved outcomes in patients with Frasier syndrome. Furthermore, collaborations between research institutions, pharmaceutical companies, and advocacy groups can help drive research on better diagnostic tools and treatment modalities.

Key Features of the Study:

This report provides in-depth analysis of the global Frasier syndrome market, including market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, with 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global Frasier syndrome market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global Frasier syndrome market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Frasier syndrome market

Frasier Syndrome Market Segmentation:

By Test Type
- Genetic Testing
- Ultrasound Testing
- Others
By End User
- Hospitals
- Diagnostic Centers
- Research Institutes
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles
- Thermo Fisher Scientific
- Invitae Corporation
- GE Healthcare
- Koninklijke Philips N.V.
- Mindray Medical
- Siemens
- Canon Medical Systems Corporation
- FUJIFILM Sonosite Inc.
- ESAOTE SPA, SAMSUNGHEALTHCARE
- Empire Genomics Inc.
- BPL Medical Technologies
- Trivitron Healthcare
- Hitachi Healthcare

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Frasier Syndrome, By Test Type
- Market Frasier Syndrome, By End User
- Market Frasier Syndrome, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Rising awareness about genetic disorders
- Restraints
Limited awareness among healthcare professionals
- Opportunities
The development of targeted therapies and personalized medicine approaches
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Frasier Syndrome Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Frasier Syndrome Market, By Test Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Genetic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Ultrasound Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Frasier Syndrome Market, By End User, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

7. Frasier Syndrome Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2023and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021-2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (US$ Mn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Invitae Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GE Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Koninklijke Philips N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Mindray Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Siemens
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Invitae Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Canon Medical Systems Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
FUJIFILM Sonosite Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
ESAOTE SPA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
SAMSUNGHEALTHCARE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Empire Genomics Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
BPL Medical Technologies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Trivitron Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Hitachi Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

9. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

弗雷泽综合征市场（按测试类型、最终用户和地区）

Frasier Syndrome Market, By Test Type (Genetic Testing, Ultrasound Testing, Others), By End User (Hospitals, Diagnostic Centers, Research Institutes, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

市场动态：

本研究的主要特点

目录

第一章调查目的与前提条件

第二章市场展望

第三章市场动态、法规与趋势分析

4. 弗雷泽症候群市场 - 冠状病毒 (COVID-19) 大流行的影响

5. 弗雷泽症候群市场（按测试类型划分），2020 年至 2032 年

6. 弗雷泽症候群市场（按最终用户划分），2020 年至 2032 年

第 7 章 Frazier 症候群市场（按地区划分），2020 年至 2032 年

第八章竞争态势

第九章章节

Market Dynamics:

Key Features of the Study:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Frasier Syndrome Market - Impact of Coronavirus (COVID-19) Pandemic

5. Frasier Syndrome Market, By Test Type, 2020-2032, (US$ Mn)

6. Frasier Syndrome Market, By End User, 2020-2032, (US$ Mn)

7. Frasier Syndrome Market, By Region, 2020-2032, (US$ Mn)

8. Competitive Landscape

9. Section

弗雷泽综合征市场（按测试类型、最终用户和地区）

Frasier Syndrome Market, By Test Type (Genetic Testing, Ultrasound Testing, Others), By End User (Hospitals, Diagnostic Centers, Research Institutes, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

市场动态：

本研究的主要特点

目录

第一章 调查目的与前提条件

第二章 市场展望

第三章市场动态、法规与趋势分析

4. 弗雷泽症候群市场 - 冠状病毒 (COVID-19) 大流行的影响

5. 弗雷泽症候群市场（按测试类型划分），2020 年至 2032 年

6. 弗雷泽症候群市场（按最终用户划分），2020 年至 2032 年

第 7 章 Frazier 症候群市场（按地区划分），2020 年至 2032 年

第八章 竞争态势

第九章 章节

Market Dynamics:

Key Features of the Study:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Frasier Syndrome Market - Impact of Coronavirus (COVID-19) Pandemic

5. Frasier Syndrome Market, By Test Type, 2020-2032, (US$ Mn)

6. Frasier Syndrome Market, By End User, 2020-2032, (US$ Mn)

7. Frasier Syndrome Market, By Region, 2020-2032, (US$ Mn)

8. Competitive Landscape

9. Section

第一章调查目的与前提条件

第二章市场展望

第八章竞争态势

第九章章节